InflaRx NV (IFRX)
1.72
+0.01
(+0.58%)
USD |
NASDAQ |
Oct 02, 16:00
1.725
0.00 (0.00%)
After-Hours: 20:00
InflaRx Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | -320.9% |
| June 30, 2025 | -5.98K% |
| March 31, 2025 | |
| September 30, 2024 | 68.60% |
| Date | Value |
|---|---|
| June 30, 2024 | -5.41K% |
| March 31, 2024 | -512.0% |
| December 31, 2023 | -14.74K% |
| September 30, 2023 | -553.7% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| MediGene AG | -- |
| BioNTech SE | -169.3% |
| Immatics NV | 0.00% |
| Arrowhead Pharmaceuticals, Inc. | 91.15% |
| Oncolytics Biotech, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -61.07% |
| Return on Assets | -49.21% |
| Return on Invested Capital | -60.40% |
| Return on Net Operating Assets | -495.4% |